Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer
Status:
Terminated
Trial end date:
2019-02-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare any good and bad effects of using ramucirumab along
with the usual trastuzumab and chemotherapy to using the usual chemotherapy and trastuzumab
alone.